HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prediction of benzimidazole therapy duration with PET/CT in inoperable patients with alveolar echinococcosis.

Abstract
Alveolar echinococcosis is a rare parasitic disease, most frequently affecting the liver, as a slow-growing tumor-like lesion. If inoperable, long-term benzimidazole therapy is required, which is associated with high healthcare costs and occasionally with increased morbidity. The aim of our study was to determine the role 18F-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) in staging of patients with alveolar echinococcosis and to identify quantitative imaging parameters related to patient outcome and/or duration of benzimidazole therapy. In this single-center retrospective cohort study, 47 PET/CT performed for staging in patients with confirmed alveolar echinococcosis were analysed. In 43 patients (91%) benzimidazole therapy was initiated and was successfully stopped after a median of 870 days (766-2517) in 14/43 patients (33%). In inoperable patients, tests for trend of survivor functions displayed clear trends for longer benzimidazole therapy duration (p = 0.05; n = 25), and for longer time intervals to reach non-detectable serum concentration of Em-18 antibodies (p = 0.01, n = 15) across tertiles of SUVratio (maximum standardized uptake value in the echinococcus manifestation compared to normal liver tissue). Hence, in inoperable patients with alveolar echinococcosis, PET/CT performed for staging may predict the duration of benzimidazole therapy.
AuthorsLars Husmann, Hannes Gruenig, Caecilia S Reiner, Ansgar Deibel, Bruno Ledergerber, Virginia Liberini, Stephan Skawran, Urs J Muehlematter, Michael Messerli, Barbara Hasse, Beat Muellhaupt, Martin W Huellner
JournalScientific reports (Sci Rep) Vol. 12 Issue 1 Pg. 11392 (07 06 2022) ISSN: 2045-2322 [Electronic] England
PMID35794149 (Publication Type: Journal Article)
Copyright© 2022. The Author(s).
Chemical References
  • Benzimidazoles
Topics
  • Benzimidazoles (therapeutic use)
  • Duration of Therapy
  • Echinococcosis
  • Humans
  • Positron Emission Tomography Computed Tomography
  • Retrospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: